MedPath

Bupivacaine Hydrochloride

Rx only

Approved
Approval ID

2dc693df-3218-4a90-b3f7-21e80966a851

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Oct 1, 2023

Manufacturers
FDA

Huons Co., Ltd.

DUNS: 631099384

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Bupivacaine hydrochloride

PRODUCT DETAILS

NDC Product Code73293-0002
Application NumberANDA212822
Marketing CategoryC73584
Route of AdministrationSUBARACHNOID
Effective DateOctober 1, 2023
Generic NameBupivacaine hydrochloride

INGREDIENTS (6)

DEXTROSEInactive
Quantity: 82.5 mg in 1 mL
Code: IY9XDZ35W2
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
BUPIVACAINE HYDROCHLORIDEActive
Quantity: 7.5 mg in 1 mL
Code: 7TQO7W3VT8
Classification: ACTIR
WATERInactive
Code: 059QF0KO0R
Classification: IACT
NITROGENInactive
Code: N762921K75
Classification: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Bupivacaine Hydrochloride - FDA Drug Approval Details